Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
UBS
Baxter
Teva
Medtronic
QuintilesIMS
Queensland Health
Merck
Boehringer Ingelheim

Generated: June 24, 2018

DrugPatentWatch Database Preview

HEPARIN SODIUM IN PLASTIC CONTAINER Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Heparin Sodium In Plastic Container patents expire, and what generic alternatives are available?

Heparin Sodium In Plastic Container is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in HEPARIN SODIUM IN PLASTIC CONTAINER is heparin sodium. There are seventy-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for HEPARIN SODIUM IN PLASTIC CONTAINER
Drug patent expirations by year for HEPARIN SODIUM IN PLASTIC CONTAINER
Pharmacology for HEPARIN SODIUM IN PLASTIC CONTAINER

US Patents and Regulatory Information for HEPARIN SODIUM IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa HEPARIN SODIUM IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 017029-013 Dec 5, 1985 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa HEPARIN SODIUM IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 017029-016 Dec 5, 1985 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa HEPARIN SODIUM IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 017029-014 Dec 5, 1985 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa HEPARIN SODIUM IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 017029-015 Dec 5, 1985 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Colorcon
Dow
AstraZeneca
McKinsey
Accenture
QuintilesIMS
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.